These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32515246)

  • 1. Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform.
    George MJ; Kleveland O; Garcia-Hernandez J; Palmen J; Lovering R; Wiseth R; Aukrust P; Engmann J; Damås JK; Hingorani AD; Gullestad L; Casas JP; Ueland T
    J Am Heart Assoc; 2020 Jun; 9(12):e015628. PubMed ID: 32515246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction.
    Ueland T; Kleveland O; Michelsen AE; Wiseth R; Damås JK; Holven KB; Aukrust P; Gullestad L; Yndestad A; Halvorsen B
    Int J Cardiol; 2019 Jan; 274():348-350. PubMed ID: 29961573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction.
    Kleveland O; Ueland T; Kunszt G; Bratlie M; Yndestad A; Broch K; Holte E; Ryan L; Amundsen BH; Bendz B; Aakhus S; Espevik T; Halvorsen B; Mollnes TE; Wiseth R; Gullestad L; Aukrust P; Damås JK
    Int J Cardiol; 2018 Nov; 271():1-7. PubMed ID: 29961572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    Broch K; Anstensrud AK; Woxholt S; Sharma K; Tøllefsen IM; Bendz B; Aakhus S; Ueland T; Amundsen BH; Damås JK; Berg ES; Bjørkelund E; Bendz C; Hopp E; Kleveland O; Stensæth KH; Opdahl A; Kløw NE; Seljeflot I; Andersen GØ; Wiseth R; Aukrust P; Gullestad L
    J Am Coll Cardiol; 2021 Apr; 77(15):1845-1855. PubMed ID: 33858620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.
    Orrem HL; Nilsson PH; Pischke SE; Kleveland O; Yndestad A; Ekholt K; Damås JK; Espevik T; Bendz B; Halvorsen B; Gregersen I; Wiseth R; Andersen GØ; Ueland T; Gullestad L; Aukrust P; Barratt-Due A; Mollnes TE
    Front Immunol; 2018; 9():2035. PubMed ID: 30258440
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.
    Kleveland O; Kunszt G; Bratlie M; Ueland T; Broch K; Holte E; Michelsen AE; Bendz B; Amundsen BH; Espevik T; Aakhus S; Damås JK; Aukrust P; Wiseth R; Gullestad L
    Eur Heart J; 2016 Aug; 37(30):2406-13. PubMed ID: 27161611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction.
    Helseth R; Kleveland O; Ueland T; Wiseth R; Damas JK; Broch K; Michelsen A; Bendz B; Gullestad L; Aukrust P; Seljeflot I
    Open Heart; 2021 May; 8(1):. PubMed ID: 33972404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction.
    Shavadia JS; Granger CB; Alemayehu W; Westerhout CM; Povsic TJ; Brener SJ; van Diepen S; Defilippi C; Armstrong PW
    Am Heart J; 2020 Feb; 220():137-144. PubMed ID: 31812755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial.
    Huse C; Anstensrud AK; Michelsen AE; Ueland T; Broch K; Woxholt S; Yang K; Sharma K; Tøllefsen IM; Bendz B; Amundsen BH; Damås JK; Berg ES; Bjørkelund E; Quiles-Jiménez A; Bjerkeli V; Bendz C; Kleveland O; Stensaeth KH; Opdahl A; Kløw NE; Andersen GØ; Wiseth R; Halvorsen B; Gullestad L; Seljeflot I; Aukrust P; Osnes L; Dahl TB
    EBioMedicine; 2022 Jun; 80():104013. PubMed ID: 35504178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction.
    Holte E; Kleveland O; Ueland T; Kunszt G; Bratlie M; Broch K; Michelsen AE; Bendz B; Amundsen BH; Aakhus S; Damås JK; Gullestad L; Aukrust P; Wiseth R
    Heart; 2017 Oct; 103(19):1521-1527. PubMed ID: 28432157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions.
    Jacob J; Ngo D; Finkel N; Pitts R; Gleim S; Benson MD; Keyes MJ; Farrell LA; Morgan T; Jennings LL; Gerszten RE
    Circulation; 2018 Mar; 137(12):1270-1277. PubMed ID: 29222138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial).
    Erlinge D; Koul S; Eriksson P; Scherstén F; Omerovic E; Linder R; Östlund OP; Wallentin L; Fröbert O; James S
    Am Heart J; 2016 May; 175():36-46. PubMed ID: 27179722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Troponin Assays With Improved Analytical Quality: A Trade-Off Between Enhanced Diagnostic Performance and Reduced Long-Term Prognostic Value.
    Tjora HL; Steiro OT; Langørgen J; Bjørneklett R; Nygård OK; Skadberg Ø; Bonarjee VVS; Collinson P; Omland T; Vikenes K; Aakre KM
    J Am Heart Assoc; 2020 Dec; 9(23):e017465. PubMed ID: 33238783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ST-Segment-Elevation Myocardial Infarction Regionalization Programs on the Treatment and Outcomes of Patients Diagnosed With Non-ST-Segment-Elevation Myocardial Infarction.
    Montoy JCC; Shen YC; Brindis RG; Krumholz HM; Hsia RY
    J Am Heart Assoc; 2021 Feb; 10(3):e016932. PubMed ID: 33470136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alirocumab in Acute Myocardial Infarction: Results From the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT).
    Trankle CR; Wohlford G; Buckley LF; Kadariya D; Ravindra K; Markley R; Park TS; Potere N; Van Tassell BW; Abbate A
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):266-269. PubMed ID: 31356537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.
    Abbate A; Trankle CR; Buckley LF; Lipinski MJ; Appleton D; Kadariya D; Canada JM; Carbone S; Roberts CS; Abouzaki N; Melchior R; Christopher S; Turlington J; Mueller G; Garnett J; Thomas C; Markley R; Wohlford GF; Puckett L; Medina de Chazal H; Chiabrando JG; Bressi E; Del Buono MG; Schatz A; Vo C; Dixon DL; Biondi-Zoccai GG; Kontos MC; Van Tassell BW
    J Am Heart Assoc; 2020 Mar; 9(5):e014941. PubMed ID: 32122219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway (FamouS Triage): ruling out a myocardial infarction at home with the modified HEART score.
    Ishak M; Ali D; Fokkert MJ; Slingerland RJ; Tolsma RT; Badings E; van der Sluis A; van Eenennaam F; Mosterd A; Ten Berg JM; van 't Hof AW
    Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):102-110. PubMed ID: 28084079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics in Hypothermia as Adjunctive Therapy in Patients with ST-Segment Elevation Myocardial Infarction: A CHILL-MI Substudy.
    Mohammad MA; Noc M; Lang I; Holzer M; Clemmensen P; Jensen U; Metzler B; Erlinge D
    Ther Hypothermia Temp Manag; 2017 Sep; 7(3):152-161. PubMed ID: 28437237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015.
    Puymirat E; Simon T; Cayla G; Cottin Y; Elbaz M; Coste P; Lemesle G; Motreff P; Popovic B; Khalife K; Labèque JN; Perret T; Le Ray C; Orion L; Jouve B; Blanchard D; Peycher P; Silvain J; Steg PG; Goldstein P; Guéret P; Belle L; Aissaoui N; Ferrières J; Schiele F; Danchin N;
    Circulation; 2017 Nov; 136(20):1908-1919. PubMed ID: 28844989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.